After receiving the test results, you should discuss management options with your patient. Hancock et al. We provide consults from patient educators, who are genetic counselors, tailored to help address any questions your patients may have. Myriad myRisk® hereditary cancer testing is a scientific advancement revolutionizing hereditary cancer testing. (2019) Clinical experience across the fetal-fraction spectrum for a noninvasive prenatal screen with low test-failure. You can view a list of these institutions here. Consults. Studies have shown that testing with Myriad myRisk increases mutation detection between 40 and 50 percent. Scientific publications consisting of clinically meaningful information have been published in peer reviewed journals over the past 5 years, Invested in research over the past 5 years. “Myriad believes that a patient’s genetic information is private and confidential. We make genetic testing simple for your patients and your practice, Commitment to Providing Broad Patient Access. When your patients utilize our on-demand or scheduled Patient Education service, you’ll receive detailed notes from the consult. myVision™ is the most advanced program in the industry overseeing the classification and reclassification of uncertain variants and is part of Myriad’s commitment to patients and their families. Once completed, the patient and you will be informed if they meet guidelines for genetic testing. If you’d like us to, we can take them through a comprehensive follow-up to ensure all of their questions are answered. Doi/abs/10.1002/pd.5603. Prequel’s clinical experience study demonstrates that high sensitivity and specificity can be achieved, without having to fail samples to do so.3, Prequel delivers results to 99.9% of patients.3, Patients receive a highly, accurate result early in pregnancy regardless of body habitus, race or ethnicity, reducing patient anxiety and the risk associated with unnecessary invasive procedures.3,4, A primary focus on common aneuploidies, as recommended by societal guidelines1,2 with options for additional screening, Analyzes all 22 numbered chromosome pairs to provide additional insights into the health of the pregnancy, Clarity of your patients’ true risk with individualized positive predictive values (PPV) and residual risk estimates to help inform next steps. Our reports also include clinical management options and educational resources specific to each result. ( 2019). Ultrasound, H, Nicolaides KH. V, Santacruz B, Plana MN, Nicolaides KH. Every Myriad myRisk test report includes: The Myriad myRisk Genetic Test Result and; The Myriad myRisk Management Tool – a personalized cancer risk and management guide based on professional medical society guidelines. Consults. Patients input personal and family history into myGeneHistory. Broad in-network status with health plans, Financial assistance and payment plans, for those that qualify, Personalized cost estimates for prenatal screens. Knowing your patient’s hereditary cancer risk is critical when it comes to making treatment decisions. The Myriad Prequel Prenatal Screen is a noninvasive prenatal screen that uses cell-free DNA (cfDNA) to determine if a pregnancy is at an increased risk for common chromosome abnormalities, such as Down syndrome. For best results and to ensure all MyriadPro functionality is working properly, we recommend using the latest versions of Firefox, Chrome, Safari, or Internet Explorer. Practice Bulletin No. Copyright 2020 ©Myriad Women’s Health, Inc.All rights reserved.Myriad does not sell your personal data. Ultrasound, RW, Hansen J. Prenatal and postnatal prevalence of Turner’s, Illumina, Inc. Analytical Validation of the, ® prenatal test: Enhanced Test Performance for Detecting. At Myriad Women’s Health, we provide support throughout the genetic screening process. Myriad myRisk ® hereditary cancer testing is a scientific advancement revolutionizing hereditary cancer testing. cfDNA screening has been shown to be superior to methods that use maternal age, ultrasound, and serum screening. We provide resources to help educate your patients about Myriad products. Ask your healthcare professional if testing is right for you. Blending both genetic test status and personal cancer family history, the Myriad myRisk ® hereditary cancer panel represents the next generation of hereditary cancer risk testing. The Myriad Prequel Prenatal Screen is a noninvasive prenatal screen that uses cell-free DNA (cfDNA) to determine if a pregnancy is at an increased risk for common chromosome abnormalities, such as Down syndrome. We deliver screening and testing results effectively and thoroughly so you can focus on care plans. Myriad myRisk is here to help you determine the right treatment for your patients with a report including comprehensive results and a guideline-based Medical Management Tool. Test results will be available in about two to three weeks. The Myriad myRisk report provides recommendations for managing patients with either positive or negative genetic results. 2017 Jan 1;72(1):6-8. RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. 2012. The Foresight Carrier Screening test can help couples determine if their child would be at risk for an inherited condition. Learn about the benefits of myGeneHistory and how to implement it into your practice. We provide resources to help educate your patients about Myriad products. Once completed, the consult is documented and a summary is sent back to you, their ordering provider. Our patient-friendly reports are clear and comprehensive, with patient risk information and detailed insights into each condition, curated by our team of genetic counselors. Calculated risk of chromosomal abnormalities in twin gestations. © 2020 Myriad, the Myriad logo, MyriadPro, the MyriadPro logo, Myriad myRisk Hereditary Cancer, the Myriad myRisk Hereditary Cancer logo, Myriad myPath Melanoma, the Myriad myPath Melanoma logo, Myriad myPlan Lung Cancer, the Myriad myPlan Lung Cancer logo, BRACAnalysis, the BRACAnalysis logo, COLARIS, the COLARIS logo, COLARIS AP, the COLARIS AP logo, MELARIS, the MELARIS logo, PANEXIA, the PANEXIA logo, Prolaris, the Prolaris logo, ResultsNow, the ResultsNow logo, Myriad Promise, and the Myriad Promise logo are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions.